The beneficial survival outcomes and low toxicity associated with stereotactic ablative body radiotherapy in patients with extracranial oligometastases persist in the real-world setting.
People receiving immune checkpoint inhibitor therapy for lung cancer or malignant melanoma have a significantly increased risk for cardiovascular events, observational study data show.
Patients receiving antitumor treatments may have a higher risk for acquiring SARS-CoV-2 infection than the general population, but overall the incidence appears to be low, say Italian researchers.